{
  "chunk_id": "VIII_ii_2_C_7",
  "content": "/>\nVIII.ii.2.C.1.b\n.\nDate Disabilities Became Subject to Presumptive SC Based on BPOT Exposure\nThe table below shows the dates on which the BPOT disabilities became subject to presumptive SC.\nDisability\nEffective Date\nChronic respiratory illnesses:\nasthma\nrhinitis, and\nsinusitis, to include rhinosinusitis.\nImportant\n:\nUnder historical 38 CFR 3.320, these conditions were required to have manifested within 10 years of separation from a period of active duty.\nHistorical 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.\nAugust 5, 2021\nSpecific rare respiratory cancers:\nsquamous cell carcinoma (SCC) of the larynx\nSCC of the trachea\nadenocarcinoma of the trachea\nsalivary gland-type tumors of the trachea\nadenosquamous carcinoma of the lung\nlarge cell carcinoma of the lung\nsalivary gland-type tumors of the lung\nsarcomatoid carcinoma of the lung, and\ntypical and atypical carcinoid of the lung.\nImportant\n:Â  This historical provision in 38 CFR 3.320 was superseded by the PACT Act on August 10, 2022.\nApril 26, 2022\nDisabilities listed in\n38 U.S.C. 1120\n:\nhead cancer of any type\nneck cancer of any type\nrespiratory cancer of any type\ngastrointestinal cancer of any type\nreproductive cancer of any type\nlymphoma cancer of any type\nkidney cancer\nbrain cancer\nmelanoma\npancreatic cancer\nchronic bronchitis\nchronic obstructive pulmonary disease\nconstrictive bronchiolitis or obliterative bronchiolitis\nemphysema\ngranulomatous disease\ninterstitial lung disease\npleuritis\npulmonary fibrosis\nsarcoidosis\nglioblastoma\nasthma diagnosed after service\nchronic sinusitis, and\nchronic rhinitis.\nAugust 10, 2022\nUnder\n38 CFR 3.320a\n:\nurinary bladder cancer, including over-lapping sites of the bladder, and\nureter cancer, including the ureteric orifice, and urachus.\nJanuary 2, 2025\nUnder\n38 CFR 3.320b\n:\nacute leukemias\nchronic leukemias\nmultiple myelomas, including monoclonal gammopathy of undetermined significance\nmyelodysplastic syndromes, and\nmyelofibrosis.\nJanuary 10, 2025",
  "title": "M21-1, Part VIII, Subpart ii, Chapter 2, Section C - Rating Claims Based on Exposure to Burn Pits and Other Toxins, Including Fine Particulate Matter (BPOT)",
  "citation": "Part VIII, Subpart ii, Chapter 2, Section C",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177443/M21-1-Part-VIII-Subpart-ii-Chapter-2-Section-C-Rating-Claims-Based-on-Exposure-to-Burn-Pits-and-Other-Toxins-Including-Fine-Particulate-Matter-BPOT",
  "updated": "",
  "scraped_at": "2025-06-16T22:57:23.049292",
  "tags": [
    "m21-1"
  ]
}